Platinum microquantities were determined in plasma of patients affected by lung carcinoma during treatment with radiotherapy (RT) and concurrent low-dose continuous infusion ofcis-dichlorodiammineplatinum(II) (CDDP). RT was given at 50 Gy in continuous course; CDDP was continuously infused at 4 mg/m2 daily for 100h/week for 5 weeks, and the infusions were separated by 68h of rest. The percentage of free drug versus total drug in plasma was about 3%. It did not vary with therapy duration and was not significantly different from that found in 5-day continuous infusions at much higher daily doses. Never-theless, maximal values of free Pt in plasma were very low and agreed with the low level of CDDP toxicity encountered on the present administration schedule.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Bannister S, Sternson LA, Repta AJ, James GW (1977) Measurement of free-circulatingcis-dichlorodiammineplatinum(II) in plasma. Clin Chem 23: 2258–2262
Bedini AV, Tavecchio L, Milani F, Gramaglia A, Spreafico C, Marchiano A, Ravasi G (1993) Non-resectable stage III a-b Lung carinoma: a phase II study on continuous infusion of cisplatin and concurrent radiotherapy (plus adjuvant surgery). Lung Cancer 10: 73–84
Belliveau JF, Posner MR, Ferrari L, Crabtree GW, Cummings FJ, Wiemann MC, O'Leary GP Jr, Griffin H, Phaneuf MA, O'Rourke A, Calabresi P (1986) Cisplatin administered as continuous 5-day infusion: plasma platinum levels and urine platinum excretion. Cancer Treat Rep 70: 1215–1217
Curran WJ, Stafford PM (1990) Lack of apparent difference in outcome between clinically staged IIIa and IIIb non-small-cell lung cancer treated with radiation therapy. J Clin Oncol 8: 409–415
Dominici C, Alimonti A, Caroli S, Petrucci F, Castello MA (1986) Chemotherapeutic agent cisplatin monitoring in biological fluids by means of inductively coupled plasma emission spectrometry (ICP-AES). Clin Chim Acta 158: 207–215
Dominici C, Petrucci F, Caroli S, Alimonti A, Clerico A, Castello MA (1989) A pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors. J Clin Oncol 7: 100–107
Hazuka MB, Bunn PA Jr, Crowley J (1991) Maximum tolerated dose for low-dose continuous infusion cisplatin. Int J Radiat Oncol Biol Phys 21: 869–870
Johnson DH, Einhorn LH, Bartolucci A (1990) Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med 113: 33–38
Powell MJD (1964) An efficient method for finding the minimum of a function of several variables without calculating derivatives. Comput J 7: 155–162
Schaake-Koning C, Van den Bogaert W, Dalesio O, et al (1992) Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524–530
About this article
Cite this article
Morazzoni, F., Canevali, C., Moschetti, I. et al. Determination of platinum in plasma of patients affected by inoperable lung carcinoma treated with radiotherapy and concurrent low-dose continuous infusion ofcis-dichlorodiammine platinum(II). Cancer Chemother. Pharmacol. 35, 529–532 (1995). https://doi.org/10.1007/BF00686840
- Continuous venous infusion
- Lung carcinoma